Dr. Qadan is a surgical oncologist and board-certified surgical specialist at Massachusetts General Hospital. He is a clinical lead for Phase III trials of Halozyme's pancreatic cancer drug PEGPH20. He also serves as an Assistant Professor of Surgery at Harvard Medical School.

MOTAZ QADAN, M.D., PH.D.
Massachusetts General Hospital